摘要
世界卫生组织的数据显示,恶性肿瘤的发病率及死亡率呈逐年上升趋势。2000年全球约有1000万人罹患恶性肿瘤,其中约620万死于各种恶性肿瘤。预计到2020年每年新发的病人将达1500万,这表明恶性肿瘤已成为继心脑血管疾病后的重要致死性疾病。因此,恶性肿瘤的防治策略已经成为今下医学研究领域的热点。而中医药,特别是"有毒"中药在恶性肿瘤防治中的作用日渐受到重视,如1979年哈尔滨医科大学张亭栋等报道应用以As2O3为主的癌灵一号注射液治疗急性早幼粒细胞白血(acute promyelocytic leukemia,APL)获得成功,使得"有毒"中药在治疗恶性肿瘤中的作用日渐受到关注。该文主要就"有毒"中药在恶性肿瘤防治中的作用加以论述。
According to the data of WHO, there is an upward trend in morbidity and mortality of malignant tumor. About 10 millions people suffered from malignant tumor in 2000,6200 thousand died finally, and this number would raise to 1500 thousand until 2020. So it shows that malignant tumor has become secondary fatal desease. Fortunately, the prevention and treatment strategies of malignant tumor have become hotspots in the field of medical research, and more and more attention has been paid on toxic Chinese medicine. For example, ZHANG Tingdong who was from Harbin Medicine University, made use of white arsenic for treating acute promyeloeytic leukemia successfully, Which made toxic Chinese medicine get more and more attention. Above all, we mainly discuss toxic Chinese medicine＇s function on prevention and treatment of malignant tumor in this article.
出处
《辽宁中医药大学学报》
CAS
2013年第8期160-162,共3页
Journal of Liaoning University of Traditional Chinese Medicine
关键词
有毒中药
恶性肿瘤
防治
toxic Chinese medicine
malignant tumor
prevention and treatment
